225 related articles for article (PubMed ID: 30017317)
1. Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Med Chem Lett; 2018 Sep; 28(17):2910-2913. PubMed ID: 30017317
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.
Gabr MT; Abdel-Raziq MS
Bioorg Chem; 2018 Oct; 80():245-252. PubMed ID: 29966870
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
[TBL] [Abstract][Full Text] [Related]
4. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
[TBL] [Abstract][Full Text] [Related]
5. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
[TBL] [Abstract][Full Text] [Related]
6. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
Green KD; Fosso MY; Garneau-Tsodikova S
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544832
[TBL] [Abstract][Full Text] [Related]
8. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2H-isoquilin-3-one derivates.
Zhao XJ; Gong DM; Jiang YR; Guo D; Zhu Y; Deng YC
Eur J Med Chem; 2017 Sep; 138():738-747. PubMed ID: 28728106
[TBL] [Abstract][Full Text] [Related]
9. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
[TBL] [Abstract][Full Text] [Related]
10. Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation.
Damuka N; Kammari K; Potshangbam AM; Rathore RS; Kondapi AK; Vindal V
Pharmacol Rep; 2020 Jun; 72(3):705-718. PubMed ID: 32200493
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new N-(5,6-methylenedioxybenzothiazole-2-yl)-2-[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE-1 inhibitory activities.
Tutuş B; Kaya AZ; Baz Y; Evren AE; Sağlik Özkan BN; Yurttaş L
Drug Dev Res; 2024 Jun; 85(4):e22214. PubMed ID: 38816986
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
16. Novel Deoxyvasicinone-Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer's Disease.
Du H; Liu X; Xie J; Ma F
ACS Chem Neurosci; 2019 May; 10(5):2397-2407. PubMed ID: 30720268
[TBL] [Abstract][Full Text] [Related]
17. From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold.
Rampa A; Mancini F; De Simone A; Falchi F; Belluti F; Di Martino RM; Gobbi S; Andrisano V; Tarozzi A; Bartolini M; Cavalli A; Bisi A
Bioorg Med Chem Lett; 2015 Jul; 25(14):2804-8. PubMed ID: 26003339
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of dual-target inhibitors for the treatment of Alzheimer's disease.
Zhai J; Hao C; Wang X; Cao Y; Pan Y; Zhou M; Sun J; Li C
Arch Pharm (Weinheim); 2024 May; 357(5):e2300693. PubMed ID: 38332316
[TBL] [Abstract][Full Text] [Related]
19. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
Akrami H; Mirjalili BF; Khoobi M; Nadri H; Moradi A; Sakhteman A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Sep; 84():375-81. PubMed ID: 25036795
[TBL] [Abstract][Full Text] [Related]
20. Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
Ortiz CJC; Damasio CM; Pruccoli L; Nadur NF; de Azevedo LL; Guedes IA; Dardenne LE; Kümmerle AE; Tarozzi A; Viegas C
Neurochem Res; 2020 Dec; 45(12):3003-3020. PubMed ID: 33079324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
